Extract notice to the Minister

Sandoz Dapagliflozin

Common name / Subject : dapagliflozine (insuffisance cardiaque, fraction d'éjection >40%)
Name of the manufacturer : Sandoz
Form :
Dosage :

Indication :

INESSS' Recommendation
Inscription – Sous conditions

Minister's decisions
Inscrire sur les listes des médicaments - Médicament d'exception (2026-04-01)

Evaluation published on April 01, 2026

Subscribe to our newsletter now

Subscription